Invesco Ltd. Vanda Pharmaceuticals Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Invesco Ltd. holds 226,743 shares of VNDA stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

226,743

Previous 303,519 25.3%

Holding current value

$1.07 Million

Previous $1.71 Million 37.98%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.61 - $6.34 $353,937 - $486,759	-76,776 Reduced 25.3%	226,743 $1.06 Million
Q2 2024 Aug 13, 2024	SELL	$3.91 - $6.5 $106,039 - $176,280	-27,120 Reduced 8.2%	303,519 $1.71 Million
Q1 2024 May 14, 2024	BUY	$3.47 - $4.61 $678,908 - $901,951	195,651 Added 144.94%	330,639 $1.36 Million
Q4 2023 Feb 12, 2024	SELL	$3.38 - $4.58 $35,554 - $48,177	-10,519 Reduced 7.23%	134,988 $569,000
Q3 2023 Nov 13, 2023	SELL	$4.28 - $6.57 $930,052 - $1.43 Million	-217,302 Reduced 59.89%	145,507 $628,000
Q2 2023 Aug 11, 2023	SELL	$5.9 - $6.95 $35,577 - $41,908	-6,030 Reduced 1.63%	362,809 $2.39 Million
Q1 2023 May 12, 2023	BUY	$6.18 - $7.99 $59,290 - $76,656	9,594 Added 2.67%	368,839 $2.5 Million
Q4 2022 Feb 13, 2023	BUY	$6.87 - $10.96 $382,184 - $609,715	55,631 Added 18.32%	359,245 $2.65 Million
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $43,792 - $54,554	-4,639 Reduced 1.5%	303,614 $3 Million
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $94,701 - $120,436	-10,172 Reduced 3.19%	308,253 $3.36 Million
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $125,603 - $191,764	11,587 Added 3.78%	318,425 $3.6 Million
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $184,890 - $249,113	-11,784 Reduced 3.7%	306,838 $4.81 Million
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $178,934 - $247,944	-11,657 Reduced 3.53%	318,622 $5.46 Million
Q2 2021 Aug 17, 2021	BUY	$15.71 - $21.51 $141,060 - $193,138	8,979 Added 2.79%	330,279 $7.11 Million
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $72,803 - $110,019	-5,425 Reduced 1.66%	321,300 $4.83 Million
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $364,987 - $515,913	-37,358 Reduced 10.26%	326,725 $4.29 Million
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $13.5 Million - $17.4 Million	-1,443,707 Reduced 79.86%	364,083 $3.52 Million
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $14.3 Million - $17.8 Million	1,481,606 Added 454.22%	1,807,790 $20.7 Million
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $7.31 Million - $16.4 Million	-975,017 Reduced 74.93%	326,184 $3.38 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $1.75 Million - $2.46 Million	-141,012 Reduced 9.78%	1,301,201 $21.4 Million
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $968,961 - $1.25 Million	-78,970 Reduced 5.19%	1,442,213 $19.2 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $327,899 - $462,296	24,525 Added 1.64%	1,521,183 $21.4 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $9.95 Million - $17.6 Million	565,487 Added 60.73%	1,496,658 $27.5 Million
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $17.7 Million - $29.3 Million	931,171 New	931,171 $24.3 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $268M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account